Our study shows that the administration of the mitochondrial antioxidant MitoQ prevents the development of cardiac fibrosis and the increase in collagen I, TGF-β, and CTGF synthesis in rats with MI. The gene discussed is TGFB1; the disease is myocardial infarction.